Optimal Medical Management in Patients with Renovascular Hypertension Olga BalafaRigas KalaitzidisKostas C. Siamopoulos Therapy in Practice 15 March 2013 Pages: 71 - 78
Pharmacogenetics in Cardiovascular Disorders: An Update on the Principal Drugs Irene M. PredazziRuggiero MangoGiuseppe Novelli Review Article 29 March 2013 Pages: 79 - 85
Review of Challenges in Optimizing Oral Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation Maria M. FernandezBirgitta von SchéeleWinghan Jacqueline Kwong Review Article 10 April 2013 Pages: 87 - 102
Disparity in the Application of Guideline-Based Medical Therapy after Percutaneous Coronary Intervention: Analysis from the Japanese Prospective Multicenter Registry Ayaka EndoShun KohsakaKeiichi Fukuda Original Research Article 13 April 2013 Pages: 103 - 112
Pharmacokinetics and Pharmacodynamics of the Antiplatelet Combination Aspirin (Acetylsalicylic Acid) Plus Extended-Release Dipyridamole Are Not Altered by Coadministration with the Potent CYP2C19 Inhibitor Omeprazole Elliot OffmanMichael J. SchobelockWolfgang Eisert Original Research Article 27 March 2013 Pages: 113 - 120
Predicting the Impact of Polypill Use in a Metabolic Syndrome Population: An Effectiveness and Cost-Effectiveness Analysis Ella ZomerAlice OwenDanny Liew Original Research Article 27 March 2013 Pages: 121 - 128
Placebo Effect and Efficacy of Nebivolol in Patients with Hypertension not Controlled with Lisinopril or Losartan: A Phase IV, Randomized, Placebo-Controlled Trial Robert J. WeissManfred StapffYuhua Lin Original Research Article 22 March 2013 Pages: 129 - 140
Irbesartan/Amlodipine: A Review of its Use in Adult Patients with Essential Hypertension Not Adequately Controlled with Monotherapy Karly P. Garnock-Jones Adis Drug Evaluation 21 March 2013 Pages: 141 - 150